Joe White
Family Medicine · Joshua, TXNPI 1487650123
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,425 of the $7,980 with a category attached, or 68.0%. AbbVie accounts for 74.1% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $3,574 and has fallen 99.3% since, to $24 in 2024. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $38.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Supernus Pharmaceuticals, Inc.$319
- Pfizer$226
- Amarin Pharma, Inc.$176
- AstraZeneca$156
- Adlon Therapeutics L.p.$118
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$5,42568%
- Food & beverage$2,45131%
- Education$1051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $5,914 |
| Supernus Pharmaceuticals, Inc. | 23 | $319 |
| Pfizer | 33 | $226 |
| Amarin Pharma, Inc. | 18 | $176 |
| AstraZeneca | 9 | $156 |
| Adlon Therapeutics L.p. | 7 | $118 |
| Astellas Pharma US Inc | 3 | $105 |
| Novo Nordisk | 7 | $104 |
| Amgen | 6 | $81 |
| Ironshore Pharmaceuticals Inc. | 2 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $75 |
| Tris Pharma Inc | 4 | $72 |
| GSK | 5 | $68 |
| Neos Therapeutics, LP | 3 | $58 |
| Indivior Inc. | 3 | $51 |
| Merck | 3 | $42 |
| Johnson & Johnson | 3 | $36 |
| Boehringer Ingelheim | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 3 | $31 |
| Orexo US, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Abbott | 1 | $24 |
| Novartis | 2 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $22 |
| Lilly USA, LLC | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
| Antares Pharma, Inc. | 1 | $11 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$5,425
How this compares
$7,980 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Joshua
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.